Trial Outcomes & Findings for Prevalence of Dry Eyes in Diabetics Compared to Non Diabetics (NCT NCT01450787)
NCT ID: NCT01450787
Last Updated: 2013-09-30
Results Overview
Conjunctival staining with lissamine green dye is measured at the time of the evaluation on a scale from 0 to 5 using the oxford scoring system, with 5 being the most severe staining.
TERMINATED
63 participants
at the time of the evaluation
2013-09-30
Participant Flow
Subjects were enrolled randomly. Consecutive patients in a private ophthalmology clinic that met inclusion criteria were asked to participate at the time of an already scheduled exam. The non-diabetic group recruitment stopped once the target number of subjects enrolled. The diabetic group recruitment continued until the study was terminated.
Being that there was no intervention and the study only involved taking measurements at the time of the exam, there was no transition required. Any eligible patient that was willing to participate was included. Consecutive diabetic patients and consecutive non-diabetic patients that met criteria were offered the opportunity to enroll.
Participant milestones
| Measure |
Diabetics
diabetics over age 40
|
Non Diabetics
non diabetics over age 40
|
|---|---|---|
|
Overall Study
STARTED
|
38
|
25
|
|
Overall Study
COMPLETED
|
38
|
25
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Prevalence of Dry Eyes in Diabetics Compared to Non Diabetics
Baseline characteristics by cohort
| Measure |
Diabetics
n=38 Participants
diabetics over age 40
|
Non Diabetics
n=25 Participants
non diabetics over age 40
|
Total
n=63 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Customized
|
38 participants
n=5 Participants
|
25 participants
n=7 Participants
|
63 participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
22 Participants
n=5 Participants
|
21 Participants
n=7 Participants
|
43 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
16 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
20 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
38 participants
n=5 Participants
|
25 participants
n=7 Participants
|
63 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: at the time of the evaluationPopulation: There were 38 consecutive diabetics over 40 years of age and 25 consecutive non-diabetics over 40 years of age that qualified and agreed to enroll. A target of 25 non-diabetics was met. The target of 50 was not met as the study was stopped when the PI changed practices. By that time, 38 diabetics enrolled.
Conjunctival staining with lissamine green dye is measured at the time of the evaluation on a scale from 0 to 5 using the oxford scoring system, with 5 being the most severe staining.
Outcome measures
| Measure |
Diabetics
n=38 Participants
diabetics over age 40
|
Non Diabetics
n=50 eyes
non diabetics over age 40
|
|---|---|---|
|
Conjunctival Staining Score
|
2.72 units on a scale
Standard Error 0.16
|
2.19 units on a scale
Standard Error 0.19
|
SECONDARY outcome
Timeframe: at the time of the examPopulation: Tear film osmolarity was measured in all patients, but two patients in the diabetic group had an insufficient tear film to obtain a reading. Therefore, only 36 diabetics were included.
The tear film osmolarity is measured at the time of the exam.
Outcome measures
| Measure |
Diabetics
n=72 eyes
diabetics over age 40
|
Non Diabetics
n=50 eyes
non diabetics over age 40
|
|---|---|---|
|
Tear Film Osmolarity
|
303.41 mOsml/L
Standard Error 2.03
|
312.06 mOsml/L
Standard Error 3.05
|
OTHER_PRE_SPECIFIED outcome
Timeframe: at the time of the examPopulation: All patients completed the OSDI survey
The ocular surface disease index survey in completed at the time of the exam. This scale ranges from 0 to 100 higher scores representing greater disability.
Outcome measures
| Measure |
Diabetics
n=38 Participants
diabetics over age 40
|
Non Diabetics
n=25 Participants
non diabetics over age 40
|
|---|---|---|
|
OSDI Score
|
19.58 units on a scale
Standard Error 2.62
|
27.50 units on a scale
Standard Error 4.60
|
OTHER_PRE_SPECIFIED outcome
Timeframe: at the time of the examPopulation: Each patient underwent schirmer testing
The schirmer tear production test with anesthesia is completed at the time of the exam in mm of tear film absorption on the test strip after five minutes. Higher scores represent greater tear production.
Outcome measures
| Measure |
Diabetics
n=76 eyes
diabetics over age 40
|
Non Diabetics
n=50 eyes
non diabetics over age 40
|
|---|---|---|
|
Schirmer Score
|
18.36 mm
Standard Error 1.06
|
15.88 mm
Standard Error 1.34
|
OTHER_PRE_SPECIFIED outcome
Timeframe: at the time of the examPopulation: Each patient underwent tear break-up time testing
The tear break-up time with fluorescein solution is measured at the time of the exam in seconds.
Outcome measures
| Measure |
Diabetics
n=76 eyes
diabetics over age 40
|
Non Diabetics
n=50 eyes
non diabetics over age 40
|
|---|---|---|
|
Tear Break-up Time
|
3.38 seconds
Standard Error 0.17
|
3.66 seconds
Standard Error 0.26
|
OTHER_PRE_SPECIFIED outcome
Timeframe: at the time of the examPopulation: All patients underwent corneal staining evaluations using fluorescein.
Corneal staining with fluorescein solution is graded at the time of the exam on a scale of 0 to 5 using the oxford scoring system with 5 being the most severe staining.
Outcome measures
| Measure |
Diabetics
n=76 eyes
diabetics over age 40
|
Non Diabetics
n=50 eyes
non diabetics over age 40
|
|---|---|---|
|
Corneal Staining
|
0.31 units on a scale
Standard Error 0.08
|
0.30 units on a scale
Standard Error 0.13
|
Adverse Events
Diabetics
Non Diabetics
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place